People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1 – which is what ...

one class of drugs in particular. Sen. Bernie Sanders (I-Vt.) noted that Novo Nordisk’s weight loss drug Ozempic sells for ...

A new study suggests semaglutide, used for diabetes and weight loss, may reduce opioid overdoses in people ... a lower risk ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

There are various ways you can keep your kidneys healthy, from staying well hydrated and exercising regularly to maintaining ...

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...